Send the following on WhatsApp
Continue to Chathttps://de.marketscreener.com/kurs/aktie/CENTOGENE-N-V-74010961/news/Centogene-N-V-s-Frontotemporale-Demenz-Genetische-Studie-EFRONT-erreicht-den-ersten-Meilenstein-b-45563872/?utm_source=whatsapp&utm_medium=social&utm_campaign=share